DAMAI ENT (01060) saw its stock price soar by 5.32% in pre-market trading on Friday, reaching HKD 0.99 per share. The surge comes on the heels of a positive profit alert issued by the company, signaling strong financial performance for the first half of its fiscal year.

According to the announcement made on November 6, DAMAI ENT expects its attributable net profit for the six months ending September 30, 2025, to be no less than RMB 500 million. This represents a significant increase from the RMB 337 million reported in the same period last year. The company attributes this impressive growth primarily to the robust performance of its Aliyu business, which has seen substantial year-on-year increases in both revenue and profit.

In addition to the strong core business performance, DAMAI ENT has also made strategic moves to optimize its asset structure. This has resulted in reduced investment portfolio risk exposure and narrower investment losses compared to the previous year. With a healthy cash reserve, the company is well-positioned to explore diversification opportunities within the entertainment industry, potentially fueling further growth in the medium to long term.